Transgene Biotek Limited (TRANSGENE BIOTEK LTD.) aktie
TRABI.BO
StängtTRANSGENE BIOTEK LTD.
Market Cap
$231,098,496
Om Transgene Biotek Limited (TRANSGENE BIOTEK LTD.) aktie
Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India. It offers a portfolio of oncology drugs, oral drug delivery, and biogenerics. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption. The company was incorporated in 1990 and is based in Sangareddy, India.
Företagsinformation
502325 Sangareddy, India
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.